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Tuberculosis (TB) causes approximately 2 million deaths every year. The problem is
escalating explosively in sub-Saharan Africa and is directly related to the increase in the
prevalence of Human Immunodeficiency Virus infection. South Africa was ranked as
having the fourth highest global incidence of TB in 2006.
In 1993, the WorId Health Organization introduced the Directly Observed Treatment
Short-Course strategy to increase efficiency of national TB programmes. The Direct
Observation of TB therapy element of the strategy has been contentious. An ideal
method of direct observation remains elusive and its role in improving adherence is
questionable.
Aim
The purpose of this research is to detennine the most effective directly observed method
for pulmonary TB offered in an urban area of South Africa.
Methods
A retrospective cohort analysis was conducted at the Prince Cyril Zulu Communicable
Diseases Centre in Durban, KwaZulu-Natal. The study population consisted of adult
patients who commenced a course of TB therapy between July 2005 and June 2006.
The effect of clinic based, family member, community health worker, lay community
health volunteer and workplace based direct observation on TB treatment outcomes, and
frequency of recurrence was detennined. A sub analysis was perfonned of the effect of
the different methods of direct observation in employed patients.
Results
Workplace based direct observation resulted in a higher frequency of successful treatment
outcomes than the other methods of Direct Observation (p < 0.001). Being a re
treatment patient was the only significant factor associated with recurrence, both for the
entire study population and for those who were employed.
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Discussion
The findings of this study are generalizable to other developing countries where
challenges in implementation of an effective TB programme such as poverty, high burden
of HIV infection, a migrant population with strong rural ties and reliance on traditional
practices to cure illness play a major role.
Recommendations
There is often no best treatment observer. Every case has to be individually evaluated
and the most acceptable and accessible treatment observer chosen. The findings of this
study strongly suggest that workplace Direct Obse ation can have a significant impact in
improving TB treatment outcomes.
(Word count = 351 words)
1ll
DECLARATION
I, Gonasagrie Nair declare that:
(i) The research reported in this dissertation, except where otherwise indicated,
is my original research.
(ii) This dissertation has not been submitted for any degree or examination at any
other university.
(iii) This dissertation does not contain other persons' data, pictures, graphs or
other information, unless specifically acknowledged as being sourced from
other persons.
(iv) This dissertation does not contain other persons' writing, unless specifically
acknowledged as being sourced from other researchers. Where other written
sources have been quoted, then:
a) their words have been re-written but the general information attributed to
them has been referenced,
b) where their exact words have been used, their writing has been placed
inside quotation marks, and referenced.
(v) Where I have reproduced a journal publication of which I am an author, I
have indicated in detail which part of the publication was actually written by
myself alone and not by other authors, editors or others.
(vi) This dissertation does not contain text, graphics or tables copied and pasted
from the Internet, unless specifically acknowledged, and the source being
detailed in the dissertation and in the References sections.
Student: G. Nair Signature: Date:
~ ~ ~~.. . l '(N,\ Is-tr I 'Supervisor: S. Knight. Signature:.' I Date:
Department of Public Health Medicine,
Nelson R Mandela School of Medicine




The assistance of the following institutions and individuals are gratefully acknowledged:
1. The Ethekwini Municipal Health Services, Mrs Sally Chetty and the staff of the
Prince Cyril Zulu Communicable Diseases Centre for allowing access to data.
2. Mrs Tonya Esterhuizen for assistance with statistical methodology and calculations.
3. Dr Stephen Knight and administrative staff of the Department of Public Health
Medicine, Nelson R Mandela School of Medicine, University of KwaZulu-Natal,
South Africa.
4. Miss S Gengiah, Dr M Khan, staff and management of The Centre of Aids
Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal,




MDR TB - Multi drug resistant tuberculosis
XDR - Extreme drug resistant TB
DO - Direct Observation of TB therapy
HIV infection- Human Immunodeficiency Virus infection
Communicable Diseases Centre - Prince Cyril Zulu Communicable Diseases Centre
VI
TABLE OF CONTENTS
ABSTRACT / SUMMARY ii
DECLARATION iv
ACKNOWLEDGEMENTS v
ACRONYMS AND ABBREVIATIONS vi
TABLE OF CONTENTS vii
TABLES ix
FIGURES x
CHAPTER I: INTRODUCTION 1
1.1 BACKGROUND 1
1.2 STATEMENT OF THE PROBLEM 4
1.3 PURPOSE OF THE RESEARCH 5
1.4 SPECIFIC OBJECTIVES OF THE RESEARCH 5
1.5. ASSUMPTION UNDERLYING THE STUDy 6
1.6 SCOPE OF THE STUDy 6
1.7 ORGANIZATION OF THE REPORT 6
1.8 SUMMARy 7
2 CHAPTER II: LITERATURE REVIEW 8
2.1 INTRODUCTION 8
2.2 PURPOSE OF THE LITERATURE REVIEW 10
2.3 SCOPE OF THE LITERATURE REVIEW 10
2.4 SOURCES OF LITERATURE REVIEWED 11
2.5 CURRENT UNDERSTANDING OF THE QUESTION IN THE STUDy 11
2.6 SUMMARY 23
3 CHAPTER Ill: METHODS 24
3.1 INTRODUCTION 24
3.2 TYPE OF RESEARCH 24
3.3 STUDY DESIGN 24
3.4 TARGET POPULATION/ STUDY SITE 24
3.5 DEFINITION OF TERMS 26
vu
3.6 STUDY POPULATION 27
3.7 DATA SOURCES 28
3.8 VARIABLES 28
3.9 BIAS AND LIMITATIONS 30
3.10 STATISTICAL ANALYSIS 31
3.11 SUMMARY 32
4 CHAPTER IV: RESULTS 34
4.1 INTRODUCTION 34
4.2 DEMOGRAPHIC CHARACTERISTICS OF THE STUDY POPULATION 34
4.3 TREATMENT OUTCOMES 37
4.4 RECURRENCE OF TB 42
4.5 SUB ANALYSIS OF EMPLOYED PATIENTS 45
4.6 SUMMARY 51




5.4 BIAS AND LIMITATIONS 58
5.5 EFFECT MODIFICATIONS 60




6.4 RECOMMENDATION FOR FURTHER STUDy 62
REFERENCES 64
APPENDIX 1 - DATA COLLECTION TOOL. 67
APPENDIX 2- ETHICAL APPROVAL TO CONDUCT STUDy 68
Vlll
TABLES
Table 1: Tuberculosis treatment outcome indicators for KwaZulu-Natal and South Africa.
5 2
Table 2: Demographic characteristics of the 1211 patients with pulmonary tuberculosis
commenced on TB treatment at the Prince Cyril Zulu Communicable Diseases Centre
from July 2005 to June 2006 35
Table 3: Treatment outcomes of 1211 pulmonary TB patients commenced on TB
treatment from July 2005 to June 2006 at the Prince Cyril Zulu Communicable Diseases
Centre 37
Table 4: Risk factors for unsuccessful treatment outcome for 1211 pulmonary TB
patients commenced on TB treatment from July 2005 to June 2006 at the Prince Cyril
Zulu Communicable Diseases Centre 40
Table 5: Risk factors for recurrence of TB for 1211 pulmonary TB patients commenced
on a course of TB treatment from July 2005 to June 2006 at the Prince Cyril Zulu
Communicable Diseases Centre 43
Table 6: Employment status for 1211 pulmonary TB patients commenced on TB therapy
from July 2005 to June 2006 at the Prince Cyril Zulu Communicable Diseases Centre.. 45
Table 7: Risk factors for unsuccessful treatment outcome for 551 employed pulmonary
TB patients commenced on TB treatment from July 2005 to June 2006 at the Prince Cyril
Zulu Communicable Diseases Centre 47
Table 7 (continued): Risk factors for unsuccessful treatment outcome for 551 employed
pulmonary TB patients commenced on TB treatment from July 2005 to June 2006 at the
Prince Cyril Zulu Communicable Diseases Centre 48
Table 8: Risk factors for recurrence of TB amongst 386 employed TB patients
commenced on TB treatment from July 2005 to June 2006 at the Prince Cyril Zulu
Communicable Diseases Centre 50
IX
FIGURES
Figure 1: Method of Direct Observation of therapy (percentage - number) of 1211
pulmonary tuberculosis patients commenced on TB treatment from July 2005 to June
2006 at the Prince Cyril Zulu Communicable Diseases Centre 36
x
Table 1: Tuberculosis treatment outcome indicators for KwaZulu-Natal and South
Africa.
WHO South Africa KwaZulu -




Successful treatment completion rate for
new smear positive cases






South Africa, is regarded as being one of the 27 countries with a high burden of
multidrug resistant TB (MDR TB) with a prevalence of 1.6% in new TB patients and
6.6 % in retreatment TB cases. 2 The Medical Research Council survey conducted in
2001 and 2002 revealed a strong association between previous treatment failure,
defaulting therapy and the development of MDR TB. 2
Prior to 1993, there was no standardization in terms of a definition for a positive
diagnosis of TB, the drugs to be utilized for successful treatment of TB and the duration
of TB treatment. In addition, a constant and consistent supply of TB drugs was not
always available and laboratory services needed to confirm a TB diagnosis were both
inadequate and inefficient. The result was that in poorly resourced settings, TB
programmes proved ineffective in controlling the epidemic. 8
As a result, in 1993, the World Health Organization (WHO) introduced the Directly
Observed Treatment Short-Course (DOTS) strategy to increase efficiency of national TB
programmes. The goal of the programme was to identifY 70 % of infectious cases and to
cure 85 % of the cases identified. South Africa adopted the World Health Organisation
DOTS strategy in 1996. 2 Direct Observation (DO) of the ingestion of TB drugs, for the
initial 2 months of therapy (intensive phase) forms one component of WHO's DOTS
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strategy to improve adherence and thus decrease the period of infectiousness and the risk
of the development of MDR TB.
WHO has reported that the DOTS strategy has proved very successful, with the
proportion of patients cured being greater than 80% and less than 10% thereof defaulting
therapy. 7 However, in South Africa. the experience of direct observation of TB treatment
has not been as successful, with more than 10% of patients reported to have defaulted
treatment in 2006.2
Treatment supporters, who have included clinic nurses, lay community health workers,
family members, school and creche teachers, shopkeepers and workplace supervisors,
have all been involved in Direct Observation of TB treatment.
1.1.1 What needs to be known?
Since] 993, different methods of Direct Observation (DO) have been utilized to enhance
adherence to TB therapy. The choice of who observes the taking of therapy (treatment
supporter) often depends on a negotiation between the health care worker and the patient.
Insight into the most practical and acceptable method of this key element of the Directly
Observed Therapy strategy is vital if the proportion of TB patients completing treatment
is to be improved and global, national and provincial TB outcomes targets are to be
achieved. Ultimately, an increase in the number of patients adhering to prescribed TB
therapy ought to occur, with a decrease in the incidence of the major public health
challenges of MDR TB and extreme drug resistant TB (XDR TB).
1.1.2 What is the importance of this study?
Studies have evaluated two or three methods ofTB Direct Observation in different
communities with varying results. Some of these studies have supported Direct
Observation whilst others have indicated that it may be irrelevant in ensuring adherence
to treatment and, ultimately, the control of the TB epidemic. There is a paucity of data on
the outcomes of workplace Direct Observation of TB treatment. Anecdotal evidence
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suggests that employed individuals may regard clinic based Direct Observation as
unacceptable because of the pressure experienced to absent themselves from their
employment for the purposes of the supporter observing them taking their medicine on a
regular basis.
1.1.3 How the study will solve the problem?
By evaluating several methods of Direct Observation, during a period in time, in one
community recording a high prevalence of HIV infection in a resource-limited setting, the
study will contribute to new knowledge. Furthermore, it will compare workplace Direct
Observation with the more traditional methods of TB treatment supervision.
1.2 STATEMENT OF THE PROBLEM
1.2.1 Research Hypothesis
Different models of Direct Observation, including that provided by workplace
supervisors, family members, community health workers and lay community volunteers
is superior to supervision provided by primary health care nurses in a resource
constrained setting and results in better TB treatment outcomes being achieved.
1.2.2 Research Questions
1) Will Direct Observation by workplace supervisors, family members, community
health workers, lay community volunteers and primary health care nurses achieve
better TB treatment outcomes?
2) Does an association exist between new and retreatment patients, patient gender, age,
employment status and type of direct observation of TB therapy, and TB treatment
outcome?
3) Is there an association between new and retreatment patients, patient gender, age,
employment status and type of observation of therapy being taken, on the recurrence
of TB in patients who have had an initial successful treatment completion for PTB.
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1.3 PURPOSE OF THE RESEARCH
The purpose of this research is to detennine the most effective method of Direct
Observation of Tuberculosis therapy for Pulmonary Tuberculosis (PTB) offered from
July 2005 to June 2006, at the Prince Cyril Zulu Communicable Diseases Centre, in an
urban area of Durban, South Africa with high a HIV/TB prevalence in order to be able to
influence policy and improve PTB treatment outcomes.
1.4 SPECIFIC OBJECTIVES OF THE RESEARCH
OBJECTIVE 1:
To describe the demographic characteristics of the patients who commenced a course of
TB therapy between July 2005 and June 2006.
OBJECTIVE 2:
To compare the effect of different methods of Direct Observation on PTB treatment
outcomes in the patient sample in conjunction with selected variables namely gender,
age, employment and re - treatment status.
OBJECTIVE 3:
To compare the effect of different methods of Direct Observation on PTB treatment
outcomes amongst employed patients in conjunction with selected variables namely
gender, age, employment and re - treatment status.
OBJECTIVE 4:
To describe risk factors for recurrence of pulmonary or extra pulmonary TB in the sample
within the subsequent two years, that is up to August 2008.
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1.5. ASSUMPTION UNDERLYING THE STUDY
It is assumed that patients did indeed receive Direct Observation by the observers/
treatment supporters to whom they were allocated, as there is no way to verify this other
than patient self-report.
1.6 SCOPE OF THE STUDY
The research addresses the various methods of Direct Observation of TB treatment
utilized by TB patients and the effect that each method has on TB treatment outcomes.
1. 7 ORGANIZATION OF THE REPORT
The body of the report is in the following format:
Chapter 1 provides background information on the TB epidemic globally and in South
Africa. The WHO DOTS strategy, which includes Direct Observation of TB treatment, is
described in this chapter. The aim and objectives of this research are listed in addition to
the definition of terms that will be used in the following chapters.
Chapter 2 focuses on the scope and the purpose of the literature reviewed. The impact
that previous studies have had on the study question, as well as the limitations and
strengths of these studies are discussed.
Chapter 3 presents research methods used in collecting the data, the study design,
research population, data sources and statistical methods employed.
Chapter 4 presents the results in appropriate tables and graphs as well as describing the
findings.
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Chapter 5 contains the section where the findings and outcomes of the research are
discussed. Limitations of the study as well as factors contributing to bias and
confounding are addressed.
Recommendations and conclusions in Chapter 6 highlight areas for policy change and
further research based on the outcomes of this study.
1.8 SUMMARY
In spite of the reality of the global burden of TB decreasing, the problem continues to
escalate in South Africa. The WHO DOTS strategy, encompassing direct observation of
therapy, has proven effective in many developing countries with high TB burdens. In
order to improve TB outcomes by improving adherence to TB therapy, it is vital to
evaluate different methods of Direct Observation of therapy and to both inform, and
facilitate policy change.
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2 CHAPTER 1I: LITERATURE REVIEW
2.1 INTRODUCTION
2.1.1 DJRECTLY OBSERVED THERAPY SHORT - COURSE (DOTS)
STRATEGY
"It is not the responsibility of the patient, but the moral and legal obligation of the health
system to ensure that an individual is cured of TB and that drug resistant strains are not
passed onto the community". 7
In response to the burgeoning TB epidemic and the failure of national TB programmes,
globally, to address the crisis adequately, the World Health Organization introduced the
Directly Observed Therapy Short-Course strategy in 1994 to increase efficiency of
national TB programmes. 8 The goal of the programme was to identify 70 % of infectious
cases of tuberculosis and to cure 85 % thereof.
The failure of national TB programmes to control the TB epidemic was largely due to the
absence of standardization in the programmatic management of this curable infectious
disease. This included the lack of a standard definition for a positive diagnosis of TB,
unavailability of a standard drug regimen for utilization in the successful treatment of TB
and no universally accepted duration of TB treatment. In addition, a constant supply of
TB drugs was not always available and inadequate laboratory services to confirm a TB
diagnosis existed. 6
The DOTS strategy aimed to address all of the above shortfalls and the following five
components constitute the basis of this strategy. 8
1) Political commitment to ensure sustained TB control activities;
2) Case detection by sputum smear microscopy;
3) Standardized short course chemotherapy with patient support and directly observed
therapy (DOT) during the intensive phase of therapy, the continuation phase of
rifampicin containing regimens and the whole re treatment regimen;
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4) A regular, uninterrupted supply of all essential anti TB drugs; and
5) A standard recording and reporting system to monitor the treatment outcomes for
patients and programmes.
2.1.2 DIRECT OBSERVATION (DO) OF TUBERCULOSIS THERAPY
There is consensus that four elements of the DOTS strategy are self-explanatory and
implementation has been successful in most settings. However, the Direct Observation of
TB therapy component of the strategy, has often been labelled as contentious. This
controversy is most often related to interpretation of what "Direct Observation of
therapy" means and to challenges in its implementation.
The World Health Organization definition of Direct Observation stipulates that every
dose of TB treatment must be ingested under direct observation by an observer who is
not a family member, at least during the intensive phase of treatment. 10 The Direct
Observation supporter must be trained by and must be accountable to the health system.
The definition is applicable for all regimens containing rifampicin, the single most
important drug in modern TB therapy which served to decrease the treatment period from
between 12 to 18 months to between 6 to 8 months. The rifampicin containing regimen
has proven to be highly effective in decreasing the TB bacterial load dramatically,
rendering the patient non-infectious early on in treatment and improving the well being of
the patient. Direct Observation was recommended to ensure that the drug is used
effectively, in order to prevent the emergence of rifampicin resistance, which may arise
because of non-adherence to TB therapy.
The aim of Direct Observation is two fold, namely, to promote adherence by directly
observing (at least during the intensive phase of treatment) that every scheduled dose of
TB treatment is ingested. The second function of Direct Observation is to provide a
supportive environment to patients who are initially often ill and are confronted with the
additional burden of prolonged pill taking, which often has unpleasant side effects.
However, it has been noted that Direct Observation is often used to "root out" possible
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defaulters who may have a negative impact on a health facilities' performance. The
judgmental attitude of health care workers serves as a deterrent for patients to re-enter the
system and continue with treatment following short intervals of treatment interruption.
Despite the adoption of the DOTS strategy, the proportion of treatment interruption in
2002 in the WHO Africa region was reported to be 11 %. 11 In response to the large
proportion of defaulters in 2002, the WHO DOTS strategy was revised, to provide more
flexibility in terms of patient support and supervision and to improve access to TB
treatment. It was advocated that Direct Observation of TB Treatment be more "context
specific" and "patient sensitive". Where previously family member support was not
considered as Direct Observation, it was now recommended as an acceptable method of
Direct Observation. 12
2.2 PURPOSE OF THE LITERATURE REVIEW
The purpose of the literature review is to assess the current knowledge of Direct
Observation of TB treatment. Does the current knowledge support Direct Observation of
treatment in comparison to self-supervision? Does it work effectively in resource-
constrained settings and is it acceptable to all role players? If direct observation of TB
therapy is generally effective and accepted, does the type or method of Direct
Observation have an impact on TB treatment outcomes? A review of the literature will
allow an evaluation of the advantages and disadvantages of the various methods of Direct
Observation.
2.3 SCOPE OF THE LITERATURE REVIEW
In this literature review, both studies that have supported direct observation and those that
have concluded that it has no positive outcome on TB treatment outcomes have been
reviewed. In addition, studies that have evaluated and compared the different methods of
Direct Observation are discussed.
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The literature review has focused on studies evaluating Direct Observation in
circumstances similar to those described in this study. There is a focus on Direct
Observation in developing countries, where traditional methods of treating disease play a
major role and the study populations are migratory with strong rural ties and
commitment. In this study, the Direct Observation supporters were not offered any
incentives, therefore an attempt was made to include, as far as possible, studies in which
no incentives or enablers were offered to improve adherence to therapy.
Studies have shown that Direct Observation has been successful in improving adherence
in countries including India, Senegal, Nepal and South Africa, whilst other studies have
demonstrated no significant effect on adherence to TB therapy in South Africa, India and
Pakistan.
2.4 SOURCES OF LITERA TURE REVIEWED
A Pubmed search for relevant articles was conducted using the University of KwaZulu-
Natal library electronic database. The key words used initially in the search were "Direct
Observation of TB therapy." In order to access articles on workplace Direct Observation
of TB therapy, the following key words were used: "workplace supervision of TB
treatment" and "public - private partnerships and TB". Additional studies were identified
through back tracing of reference lists from journal articles reviewed.
2.5 CURRENT UNDERSTANDING OF THE QUESTION IN THE STUDY
The studies included in this literature review range from observational to experimental
study designs that have been used to evaluate various methods of Direct Observation in
low resourced and developing countries. The results thereof have provided no clear
evidence of the most effective method for Direct Observation of therapy for TB patients.
Studies implemented amongst the same population and by the same research team have
produced conflicting evidence on the value of Direct Observation.
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2.5.1 SELF SUPERVISION OF TB THERAPY
Three randomized controlled trials that reported on the efficacy of self-supervision (that
is no direct observation of TB therapy by a third party) compared to other methods of
Direct Observation of TB therapy found self supervision to be equally efficacious or
. h h h d fD' Ob . 131415supenor to t e ot er met 0 s 0 trect servatlOn."
The first of these studies, a randomized controlled trial evaluating the efficacy of Direct
Observation was conducted by Zwarenstein et al. 13 in Cape Town, South Africa between
May 1994 and September 1995. The study evaluated the efficacy of Direct Observation
of TB therapy by volunteer lay health workers, clinic based health workers and self-
supervision. 13 The study showed that there were no statistically significant differences in
the success of treatment between the three options for Direct Observation of TB therapy
(p 0.136). The risk difference for lay health worker versus clinic Direct Observation was
17,2% (95 % Cl: 0.1 to 34.5). The risk difference for lay health worker versus self-
supervision was 15% (Cl: 3.7 to 33.6). However, the study did not achieve statistical
significance because of the small sample size (n = 156).
The second randomized controlled trial alluded to was also conducted amongst a similar
patient population in the Western Cape Province in South Africa by the same principal
investigator from 1994 to 1995. 14 This study demonstrated that self supervision was
superior to clinic based Direct Observation in ensuring adherence to TB treatment,
amongst new TB patients, although the WHO target of 85% being cured was not
achieved. The proportion of patients that successfully completed treatment in self-
supervision arm was 60% versus 54% in clinic based Direct Observation group. The risk
difference obtained was 6% for self-supervision versus clinic based Direct Observation
(90% Cl: 5, 1 to 17). As in the above study, the limitation of this study was the small
sample size of 216 patients a factor that did not allow the study to achieve statistical
significance.
The third randomised controlled trial was conducted between September 1996 and June
1998, in Pakistan, prior to the implementation of a national tuberculosis control program
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in that country. 15 The study, conducted in a setting with poor health infrastructure,
demonstrated that there was no statistically significant difference in treatment success
for patients receiving health worker Direct Observation (clinic based or community
health worker Direct Observation) versus family member Direct Observation (2%
difference; 95% CI- 8.6 to 11.9, P 0.75). The comparison between health worker Direct
Observation and self-supervision (-3 % difference; 95% Cl: 12.8 to 8.0; p 0.65) also did
not reveal any significant difference on TB treatment outcomes. Overall, 60% cure was
achieved, markedly below WHO targets. 15
The limitation of this study is that a larger proportion (16%) of patients randomized to
health worker Direct Observation compared to family member Direct Observation (2%),
were unable to comply with Direct Observation allocation. The authors suggested that
this could have been due to a larger number of rural patients having been randomized to
health worker Direct Observation resulting in bias.
The strength of this study resides in that it was performed under field conditions and thus
results should be generalizable to other settings in developing countries.
FACTORS ASSOCIATED WITH UNSUCCESSFUL DIRECT OBSERVATION OF TB
THERAPY
The apparent failure of Direct Observation of TB therapy has prompted further
investigations into possible contributing factors for this poor performance. A study using
qualitative and quantitative methods in Delhi, India has investigated reasons for the
failure of clinic based Direct Observation of therapy. 16 The findings and
recommendations can be extrapolated to any method of Direct Observation used in an
urban setting and has therefore been included in this literature review.
In this study, 2676 patient records were reviewed and 40 in depth interviews were
conducted amongst patients who had defaulted TB treatment whilst receiving clinic based
direct observation of TB therapy, between 1996 and 1998.
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The article highlights the issue that all role players need to accept responsibility for
adherence to TB treatment. It is not the responsibility of the patient alone. Patients have
responsibilities that extend beyond merely completing their TB treatment. They often
have obligations and responsibilities to their families to provide an income and
obligations to their employers to provide a service. Therefore, the method of Direct
Observation must be easily accessible and acceptable to the patient, allowing him/her to
continue functioning as a productive member of society.
The acceptability of Direct Observation of therapy presents challenges for both patients
and providers. According to the authors, a high proportion of defaulters is an indication
of the failure of the TB control programme as a whole. A programme is likely to exhibit
successful treatment outcomes if the model of Direct Observation used is acceptable and
user friendly. From their evaluation, laiswal et al. 16 have demonstrated that four factors
affect treatment outcomes in clinic based Direct Observation of therapy, namely,
programme factors, provider factors, the disease process issues and patient factors.
PROGRAMME FACTORS
Programme factors include the location wherein Direct Observation of therapy is actually
conducted. The site needs to be easily accessible to the poor and the sick. In addition, the
study showed that adherence to Direct Observation was higher if patients were assured of
a consistent supply of anti TB drugs.
PROVIDER FACTORS
Provider factors, including the attitude and behaviour of health care workers, had an
impact on adherence to Direct Observation. It was noted that providers often lacked
communication skills, appearing rude and unapproachable to patients. Patients often lost
confidence in health care workers who failed to manage adverse events appropriately.
The authors found that treatment interruption increased, because re- entry into the system
was difficult once a patient had been temporarily non-adherent. Non-adherent patients
were labelled "non-compliers" and unreliable and were viewed as a group that would
have a negative impact on the facility's performance.
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DISEASE FACTORS
TB disease related factors included drug side effects and the failure of health care
workers to deal with these effectively. The high pill burden of TB treatment also
increased non-adherence. The perceived response of the disease to treatment also
affected adherence. A large number of patients defaulted because they felt that there was
no improvement in their condition. Others defaulted because they became asymptomatic
soon after treatment initiation. Patients with co morbid illnesses, which affected their
ability to travel to the Direct Observation site, were also likely to default on treatment.
PATIENT FACTORS
Patient factors identified as important were the migratory nature of the population with
TB, the extent of alcohol abuse and the patients' obligations to their employers. Many
patients in this study were migrant workers with strong rural ties, who sought
employment in the city to suppOli extended families in rural areas.
The TB control programme workers tended to view certain obstacles to Direct
Observation as insurmountable and non-negotiable. Patients who could not adhere to
Direct Observation for a period often became treatment interrupters because no provision
was made for them to continue with TB treatment whilst they were away in rural areas
attending to family crises.
Employed patients did not adhere to TB treatment because clinic hours coincided with
work hours - there was a conflict between the demands of employment and the
inflexibility of the programme. Alcohol abuse amongst TB patients affected adherence as
well as the relationship with health care workers and family members.
A chart review of96 patients in California, USA, conducted between 1994 and 1997 by
Mac et al. 17 evaluated the effect of Direct Observation on treatment outcomes amongst
Vietnamese immigrants suffering from TB. The study, undertaken in a well-resourced
setting by public health clinics and private doctors, demonstrated that other patient
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factors such as their cultural background and health beliefs and practices could constitute
a barrier to adherence. Cultural backgrounds may propagate misconceptions about
treatment. The patients understanding of illness, the need to complete treatment and the
consequences of not completing treatment may affect adherence negatively.
Among the Vietnamese, there is a common belief that treatment for an ailment is usually
symptomatic and, as soon as the patient felt better, it was common practice for
interruption of treatment to occur. Herbal medication and other alternative practices to
cure ailments were relied upon and were considered a factor in non-adherence to TB
therapy.
Allopathic medicine was not considered as a suitable option for many Vietnamese people.
It was sometimes perceived as being too "strong", with the result that the patient adjusted
dosage or duration of treatment. Anecdotally, similar challenges exist in our study site at
eThekwini (Durban) as well.
2.5.2 CLINIC BASED DIRECT OBSERVATION OF TB THERAPY
The three randomized controlled trials evaluating clinic based Direct Observation, 13,14,15
discussed earlier in the chapter, have concluded that this method of Direct Observation
is not inherently superior to self-supervision or other methods of Direct Observation in
improving TB treatment outcomes.
In contrast to the above, a chart review conducted in Kerela, India by Balasubramanian
et al. 10 found that clinic Direct Observation improved successful treatment completion
rates to well above the WHO target of85% (from 55% to 95%.). However,
implementation of the Direct Observation strategy was challenging (about 26 % of
patients and health workers did not comply with Direct Observation). Two hundred
patients were included in this retrospective study, which entailed chart review and
interviews, conducted between February 1995 and February 1996. The 27 % of patients
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who were allocated to Direct Observation but who did not receive it were more likely to
exhibit treatment failure (45% versus 3%, relative risk 17; 95% Cl: 6 to 46; p < 0.001).
The limitation of this study, based on a retrospective chart review and interviews, is the
increased likelihood of recall bias. In the event of treatment failure, patients and health
workers were far less likely to admit to non-adherence to Direct Observation. The value
of this study is that it demonstrated that some kind of supervision is superior to no
supervision of treatment at all, and that other methods of Direct Observation of TB
therapy must be explored.
A retrospective chart review conducted by Mac et all? in California, USA also
demonstrated that Direct Observation by facility based health workers had a favourable
response on TB treatment outcomes. In this study with a sample size of 50 patients of
Vietnamese origin, the completion of TB therapy was 16% higher and relapse was 8%
lower in the Direct Observation group. However, the statistical significance of these
findings may be questionable, as the authors did not report confidence intervals or p
values.
Although the results of the chart review conducted by Balasubramanian et al. 10
displayed statistical significance, the findings are not as significant as the results of the
randomized controlled trials conducted by Zwarenstein et al. 13,14 and Walley et al. 15
because of study design ( the randomized controlled trial is the gold standard in terms of
study design).
FACTORS ASSOCIATED WITH FAILURE OF CLINIC BASED DIRECT
OBSERVATION OF TB THERAPY.
According to the Zwarenstein et al. 13 clinic, based Direct Observation could be
ineffective because it is often unacceptable to the patient. It is often equated to
surveillance, and may therefore appear authoritarian and demoralizing to the patient. It
robs the patient of autonomy and can be degrading. It places the burden of
responsibility to ensure patient adherence on the clinic health worker and, in this regard,
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may have a negative impact on the relationship between the patient and provider. In
addition, there is the additional financial burden to both the health system and the
patient (indirect costs associated with time away from work and travel costs). 13
Balasubramanian et al. 10 also explored reasons for non-compliance with Direct
Observation and, as in the studies undertaken in South Africa, conflict with health
worker; inconvenience and financial constraints were some of the obstacles identified.
Age and infirmity posed an obstacle to patients presenting for Direct Observation to a
health facility. The investigators found that women were less likely to participate in
Direct Observation because of the social stigma associated with having TB, lack of
confidentiality and fear of rejection from the community.
FACTORS ASSOCIATED WITH SUCCESS OF CLINIC BASED DIRECT
OBSERVATION OF TB THERAPY.
Mac et al. 17 demonstrated that, in spite of differences in culture, health beliefs and
practices, facility based Direct Observation of TB Therapy amongst Vietnamese
immigrants in the USA is effective in ensuring successful treatment completion when
compared to self-supervision. This positive impact on TB treatment outcomes is
attributed to facility based Direct Observation offering more support to the patient to
complete TB treatment, allowing more frequent monitoring of clinical response to TB
treatment and patient tracing in the event of missed doses.
2.5.3 FAMILY MEMBER DIRECT OBSERVATION OF TB THERAPY IN
COMPARISON TO COMMUNITY HEALTH WORKER DIRECT
OBSERVATION OF TB THERAPY.
In a randomized cluster trial conducted in Senegal, West Africa between June 2003 and
January 2005, with a sample size of 1522 patients, Thiam et al. II demonstrated that
family member supervision was superior to supervision by community health workers
and clinic nurses. Family member supervision achieved cures of 88%, compared with
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77% in the other two groups (RR 1.18; 95% Cl: 1.03 to 1.34). The treatment interruption
was also much lower in this group (3, 9% versus 7, 9%; RR 0.43; 95% Cl: 0.21 to 0.89).
However, the aim of this trial was to evaluate far more than merely the effect of choice of
Direct Observation of TB treatment supporter under standard of care conditions as
advocated by the National TB Control Program of Senegal, on TB treatment outcomes.
The authors recognized that Direct Observation alone was not effective in ensuring
adherence and that the degree of adherence was dependent not only on patient
characteristics, but on provider and disease factors, as demonstrated in previous studies.
16 The aim of this trial was to evaluate the effect of an intervention package designed to
increase acceptability and accessibility of Direct Observation. Health personnel received
training on effective TB management and on counselling and negotiation skills, which
proved to be effective in promoting an interactive, cordial relationship between patient
and provider. Decentralization of TB services occurred, with involvement of community
health workers. Patients chose their TB supporters and this served to strengthen the
Direct Observation strategy. Central supervision of the peripheral clinic staff by the
district health team was encouraged and, therefore, health workers possessed the
necessary knowledge to cope with any adverse events due to TB drugs.
The study design is a strength of this study. Bias was reduced because it is a randomized
controlled trial and, further, because it is a cluster-randomized trial, which would reduce
bias associated with individuals (personality-associated factors).
The limitation acknowledged by the authors is that they failed to consider the
confounding effect of HIV co- infection on TB treatment outcomes.
However, it has been noted that this trial is not generalizable and would be difficult to
duplicate under field conditions in under resourced areas because supervisors received
enhanced training and monitoring throughout the study and this does not occur under
normal programme conditions although it would be ideal and should be part of good TB
management practice. 7 In addition, the authors failed to evaluate relapse/recurrence rates,
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an outcome which is considered an important measure of the efficacy of TB treatment
following successful cure. 6
A cluster randomized trial conducted by Newell et al. 9 set in Nepal between July 2002
and July 2003 compared the efficacy of family member Direct Observation and
community worker Direct Observation on TB treatment outcomes. The outcome was that
family supervision and community worker supervision resulted in similar outcomes
(family supervision exceeded the WHO target cure rate of 85% and community worker
supervision met the WHO target). The odds ratio of success of community Direct
Observation relative to family member Direct Observation was 0.67 (95% Cl: 0.41 to
1.10; P =0.09).
FACTORS ASSOCIATED WITH SUCCESS AND FAILURE OF FAMILY MEMBER
DIRECT OBSERVATION OF TB THERAPY.
There are several reasons why family member supervision of Direct Observation should
be effective. Family members are genuinely concerned with the well-being of the patient
and this method of Direct Observation is easily accessible to the patient. However, in a
review article, Frieden et al. 7 were of the opinion that this method of Direct Observation
could have a negative impact on adherence for the following reasons. In some cultural
settings, it would be unacceptable for a family member to exert pressure on the head of
the household to modify behaviour. If the issue of TB treatment supervision created
discord within a household, the practice would most likely be abandoned in order to
preserve harmony. Furthermore, there exists a risk of family members having little
confidence in "western medicine" or not understanding the importance of ingesting TB
treatment every day.
FACTORS ASSOCIATED WITH SUCCESS AND FAILURE OF COMMUNITY
HEALTH WORKER DIRECT OBSERVATION OF TB THERAPY.
There are advantages associated with using community health workers as Direct
Observation supporters. They are accepted members of the community, share the same
cultural values, are always available and identify with the community. In addition, they
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have received basic training on TB and are aware of the obligations of all role players in
the TB programme to improve TB treatment outcomes. However, there are
disadvantages. The issue of stigma still remains. At the community level, there is an
assumption that all individuals with TB are HIV co infected. For this reason, patients
may choose clinic supervision as it may be perceived as being more discrete. 18
2.5.4 LAY COMMUNITY VOLUNTEER BASED DIRECT OBSERVATION OF
TB THERAPY
A prospective cohort study conducted by Barker et al. 19 in a rural area in South Africa
demonstrated that community volunteer based direct observation of TB Therapy (Direct
Observation mainly by shopkeepers) was as effective as direct observation provided by
professional health workers (OR= 1.32; 95% Cl: 0.82 to 2.13).1n total, 1476 patients were
included in this study conducted between January 1997 and June 1999. Three quarters
(77%) of the patients TB treatment was supervised by unpaid community volunteers.
FACTORS ASSOCIATED WITH SUCCESS AND FAILURE OF LAY COMMUNITY
VOLUNTEER DIRECT OBSERVATION OF TB THERAPY.
The advantages oflay community volunteers as Direct Observation of TB therapy
supporters resides in the fact that they are aware of the challenges faced by the
community and can thus bridge the gap between the health system and the community. 18
The disadvantages associated with using lay community volunteers as Direct Observation
supporters is that they do not receive any formal training on TB and they are not
accountable to the health system and therefore may not realize the value of adherence to
TB therapy. 18
2.5.5 WORKPLACE BASED DIRECT OBSERVATION OF TB THERAPY
Studies evaluating the effect of workplace Direct Observation of TB Therapy have
focused on public-private partnerships in TB management rather than on Direct
Observation alone.
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Studies conducted in Asia, namely India, Philippines and Nepal have demonstrated that
pubic-private partnerships have a positive impact on improving TB treatment outcomes.
However, there is a paucity of data on the effectiveness of the above partnership on TB
treatment in Africa. 20
A study, employing both qualitative and quantitative methods to evaluate the
effectiveness of workplace, non-governmental organization and public sector
management of TB in South Africa (Free State, North West and Western Cape provinces)
found that workplace management proves to be superior to the other two models. 20 In the
workplace, Direct Observation was provided by nurses in the occupational health clinics
and those patients whose TB was managed by the non-governmental organization
received Direct Observation by community volunteers. The records of 1268 patients,
who commenced treatment between January and June 2001 from six sites, were
evaluated. Although the WHO target of 85% cured was not achieved, private workplace
TB management achieved higher proportion of cure and successful treatment completion
in addition to lower proportion of defaulting and failure of TB treatment. Of the three
models, public sector management of TB had the poorest outcomes. The quality of the
study is doubtful as the authors failed to present measures of association and comment on
whether statistical significance was achieved.
Another limitation of this study is that sites were chosen in a "purposive", non-
randomized manner with differing HIV prevalence, which could have influenced TB
treatment outcomes. The authors also acknowledge that selection bias could have
occurred. Thus, sites with better previous treatment outcomes may have been
preferentially selected.
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FACTORS ASSOCIATED WITH SUCCESS AND FAILURE OF WORKPLACE
BASED DIRECT OBSERVAnON OF TB THERAPY.
The authors attribute the poor perfonnance ofthe public sector in TB treatment outcomes
to poor quality of care offered which is linked to dwindling human resources and failure
to take into account patient demands and preferences.
The superior outcome in the workplace arena is attributed to the high degree of
motivation amongst both employers and staff. Staff motivation is linked to job security
and the shame of being "paraded" if treatment is not taken. Employers or management is
motivated to ensure adherence to treatment because of loss of productivity associated
with non-adherence and the consequent deterioration in health status of workers.
2.6 SUMMARY
The studies reviewed have ranged from retrospective chart reviews to randomized
controlled trials of varying quality and generalizability and have produced conflicting
evidence on the value of Direct Observation of TB therapy. However, the lesson learnt is
that the method of Direct Observation needs to be negotiated between patient and
provider so that issues related to acceptability and accessibility are considered.
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3 CHAPTER Ill: METHODS
3.1 INTRODUCTION
The purpose of this research was to assess the effectiveness of different methods of
Direct Observation of TB Therapy offered to patients at a large TB facility in Durban,
KwaZulu-Natal.
3.2 TYPE OF RESEARCH
The study is epidemiological research.
3.3 STUDY DESIGN
The study design is an observational, analytic, retrospective cohort study.
3.4 TARGET POPULATIONISTUDY SITE
The study was conducted at the Prince Cyril Zulu Communicable Diseases Centre in
Durban, KwaZulu- Natal. The Prince Cyril Zulu Communicable Diseases Centre is the
designated clinic for the diagnosis and treatment of TB cases from north and south central
Durban, in the province of KwaZulu-Natal and experiences a large TB caseload. In 2004,
5192 patients presenting with a new episode of TB were managed in this facility. 21. This
facility serves mainly the black communities who live and work in the catchment areas of
the clinic. The majority of the patients are unemployed and indigent.
The facility was chosen for this study because a high case load of TB patients sought
health care at this clinic and it is easily accessible because of its central location and
close proximity to a taxi rank (Taxi services are the most popular and affordable mode of
transport for the majority in the community). As part of municipal health services,
treatment at this facility is free and patients need to reside in or work in the central
Durban area to qualify for care in this centre.
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Apart from management of TB this centre also offers management of sexually
transmitted infections and offers voluntary counseling and testing for HIV infection.
Direct observation of TB therapy is strongly recommended for all patients diagnosed as
having TB at the Prince Cyril Zulu Communicable Diseases Centre and is either
supervised by clinic staff, workplace based supporters, family members, lay community
volunteers or community health workers. Self supervision is not a recommended option at
this site. The choice of Direct Observation supporter is negotiated and agreed to by the
patient together with the clinician. Direct Observation of TB Therapy occurs for the
entire duration of TB treatment period (intensive phase and continuation phases of
treatment for both new and retreatment cases of TB).
Diagnosis ofPTB is based on sputum microscopy, clinical presentation and/or chest
radiography. Following the positive diagnosis of TB, the patient presents to a Direct
Observation of TB therapy nurse who provides information on dosing and common side
effects of TB medication. Patients also receive health education, which includes
information on appropriate diet and investigation of household contacts, especially,
children under 5 years of age, to exclude TB.
The Direct Observation of TB therapy nurse supervises the first dose of TB treatment and
TB treatment is dispensed for a short period, dependent on the method of direct
observation chosen.
Patients are reviewed twice during the duration of treatment to assess response to
treatment. These review visits occur at the end of the intensive phase and continuation
phases of therapy. Each assessment includes sputum microscopy for detection of acid-
fast bacilli. Chest radiography is part of the clinical evaluation only if sputum is not
available for examination or if the patients' clinical response to treatment is suboptimal.
Therefore, the decision to commence the patient on the continuation phase of treatment or
to discharge the patient is based on sputum examination, clinical response to treatment
and/ or chest radiography.
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TREATMENT REGIMEN USED.
Treatment at the Prince Cyril Communicable Diseases Centre is in accordance with the
South African National Tuberculosis Control Programme guidelines. 22 New cases of TB
receive 6 months of TB treatment (2 months of intensive phase of therapy in a fixed dose
combination of rifampicin, isoniazid, ethambutol and pyrazinamide and 4 months of
continuation phase of therapy, a combination of rifampicin and isoniazid. (Treatment is
prescribed to be taken for 5 days per week, Monday to Friday for both the intensive and
continuation phases). Re treatment TB cases receive 8 months of treatment in total,
consisting of 3 months of fixed dose combination of 4 drugs and 2 months of
streptomycin as part of the intensive phase of therapy and 5 months of a fixed dose
combination of two drugs and ethambutol as part of the continuation phase of treatment.
3.5 DEFINITION OF TERMS
CLINIC BASED DIRECT OBSERVATION OF TB THERAPY
Clinic Direct Observation of treatment, at the Prince Cyril Communicable Diseases
Centre or at a local/peripheral clinic, comprises either daily or weekly supervision.
Patients on the retreatment TB regimen, which includes streptomycin injections present
for daily Direct Observation of TB treatment. Those patients undergoing weekly
supervision of treatment receive a one-week's supply of medication to take home and
treatment is self-supervised. In the event of missed doses, patients are traced after they
have missed ten doses.
FAMILY MEMBER! COMMUNITY HEALTH WORKER! LAY COMMUNITY
VOLUNTEER! WORKPLACE SUPERVISION OF DIRECT OBSERVATION OF TB
THERAPY
Patients receive a 2 month supply of TB treatment from the TB clinic that they are
expected to deliver to the Direct Observation supporter. Direct Observation of TB
Treatment by supporters other than clinic health workers occurs daily, 5 days per week
(Monday to Friday). Workplace Direct Observation entails supervision by a workplace-
based health professional, work supervisor or employer.
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Family members and lay community health volunteer Direct Observation supporters are
expected to present together with the patient for health education and information on TB
to the Direct Observation TB therapy nurse at the Prince Cyril Zulu Communicable
Diseases Centre or to the patients local clinic. Work place supervisors receive telephonic
education on TB and the supporters' role in ensuring adherence to TB treatment. Direct
Observation supporters are relied on to record ingestion of medication on a Direct
Observation record card. They are also required to inform the health facility if the patient
fails to take TB medication.
RECURRENCE OF TB
The recurrence of TB was defined as the onset of a subsequent episode of TB following a
successful treatment outcome (either previous cure or successful treatment completion).
No differentiation was made between relapse (occurrence of infection due to same strain
of Mycobacterium tuberculosis) and re-infection (occurrence of infection secondary to a
new strain of Mycobacterium tuberculosis).
Patients' records were reviewed and recurrence was assumed to have occurred if the
patient was treated for a subsequent episode of TB. If the patient had not presented to the
site for management of a· subsequent episode of TB, an assumption was made that the
patient had not had a recurrence.
3.6 STUDY POPULATION
The study population consisted of adult patients (older than 17 years of age) who
commenced a course of TB therapy for either a first episode of pulmonary TB (PTB) or
recurrence of PTB between July 2005 and June 2006.
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SELECTION OF STUDY POPULATION
Exclusion Criteria
Patients who were excluded from the study included patients who suffered from MDR
TB or XDR TB, who were initiated on a trial of TB therapy by the attending clinician
(not confirmed PTB), who were younger than 17 years of age and those who were
transferred out to other clinics and hospitals.
3.7 DATA SOURCES
Records of all patients and the TB register for the site are electronically available.
Patients' demographic information, laboratory investigations, chest radiography reports
and clinical findings are recorded electronically on Data Care Hospital Package. The
patient information is then stored on the "Top Speed Data Base". Microsoft Excel
Programme was linked to the Top Speed Data Base and the required infonnation of
consecutive eligible patients receiving a new course of PTB treatment and being allocated
to one of the Direct Observation methods from 01 July 2005 was recorded on an Excel
spreadsheet. Information on TB recurrence could not be accessed from the Top Speed
Data Base in the manner described and was obtained by perusing through the patient
records from Data Care Hospital Package. Information on recurrence was then recorded
on the Excel spreadsheet.
3.8 VARIABLES
EXPOSURE VARIABLES:
• Clinic based direct observation of TB Therapy;
• Workplace / occupational direct observation of TB Therapy - that is, supervision by
workplace health professional, employer or work supervisor;
• Community health worker based Direct Observation of TB Therapy;
• Family member based direct observation of TB therapy;
• Direct Observation of TB therapy by a lay community volunteer;
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• Basic demographic data (race, age, gender, employment status); and
• Category of patient, that is, whether a first time episode of TB or a case of recurrent
TB.
OUTCOME VARIABLES:
Treatment outcomes are defined as follows: 22
1. Cured: Patient who is smear negative at, or one month prior to, the completion of
treatment and on at least one previous occasion.
2. Treatment completed: Patient who has completed treatment but without proof of cure.
3. Treatment Failure: Patient who remains or becomes again smear positive at five
months or later during treatment.
4. Died: Patient who dies for any reason during the course of TB treatment.
5. Treatment Interrupted: Patient whose treatment was interrupted for two months or
more.
The principal outcome "successful treatment" includes patients who were cured and those
who completed TB treatment. Patients who had failed treatment, died, who were lost to
follow up or had interrupted treatment were categorized as an "unsuccessful outcome".
RELIABILITY AND VALIDITY OF DATA SOURCE.
The reliability of the data source is dependent on the clinicians managing the patients and
recording findings on patients' chart notes in the computerized record. However, as the
source of the data is the electronic TB register for the site and the Data Care Hospital
Package, which serves as the basis for reporting outcomes to the district, provincial and
national TB offices, it is assumed that the data is generally reliable. In addition,
information and outcomes recorded in Top Speed Data Base was reconciled with patient
records in Data Care Hospital Package.
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3.9 BIAS AND LIMITATIONS
BIAS
Infonnation bias is likely as there was no means available to verify the extent of Direct
Observation of TB therapy coverage (if Direct Observation had actually occurred
according to Direct Observation agreed upon at the commencement of TB treatment).
There was no way to verify if patients had switched methods of Direct Observation
during the course of TB treatment, as this infonnation is not captured in the electronic
chart notes. Clinic based Direct Observation of TB therapy occurred either on a daily or
weekly basis and this could have resulted in bias.
CONFOUNDERS
The extent and severity of PTB may have varied in the patients allocated to the different
methods of Direct Observation. Employed patients, the majority of whom were allocated
to workplace supervision, were still able to perfonn their workplace duties adequately, in
spite of having TB, and may have had less severe TB disease and better perfonnance
scores. In order to control for this factor a sub analysis of treatment outcomes and
recurrence of TB was done amongst employed patients.
• The presence of concurrent illness, for example, HIV infection, would affect the
primary outcome variable as it would affect mortality.
• Concomitant medicine use for chronic illnesses such as hypertension and diabetes
may affect adherence negatively as it will serve to increase pill burden.
• Alcohol and drug abuse, education level and gender are factors that could all affect
adherence to TB therapy.
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STRENGTHS AND WEAKNESSES OF PROPOSED STUDY
Since it is a retrospective cohort study, the Hawthome effect would have no effect on
results (being in a study /being observed would affect the behaviour of both treatment
supporters and patients).
Testing the hypothesis in a randomised trial would be much more appropriate to control
for confounders.
3.10 STA T1ST1CAL ANALYS1S
SAMPLE SIZE CALCULAnON
A Fisher's exact test with a 0.05 two sided significance level will have 82% power to
detect the difference between a group 1 proportion, pI, of 0.7 and a group 2 proportion,
p2, of 0.8 when the sample size in each group is 400.
A sample of up to 400 participants per type of Direct Observation of TB Therapy
supporter was randomly drawn from a computerized database (excel spreadsheet) using
SPSS in the case of more than 400 participants meeting entry criteria. Where the number
of participants was limited and less than 400, all available participants were used.
STAnSTICAL METHODS
SPSS version 15.0 (SPSS Inc., Chicago, Illinois, USA) was used to analyse the data. A p
value <0.05 was considered as statistically significant.
Bivariate associations between outcomes and exposures were assessed using Pearson chi
square tests in the case of categorical exposures and independent t-tests for quantitative
variables. The outcome was dichotomized into treatment success or failure and the
exposures were compared between the outcome groups using logistic regression analysis
with odds ratios. Odds ratios were used because the outcome and exposures were
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assessed simultaneously and there was no time factor (that is, there was no time to event),
although this is a retrospective cohort study.
To account for possible confounding effects in assessing the independent association
between type of Direct Observation of TB Therapy support and outcomes, binary logistic
regression analysis was performed. Backwards stepwise models were constructed with
entry and exit probabilities set at 0.5 and 0.1 respectively, based on likelihood ratios.
Odds ratios and 95% confidence intervals were reported.
ASSOCIATIONS MEASURED
The association between successful treatment outcome and recurrence of TB were
measured with the following variables, method of direct observation of TB Therapy,
employment status, race, age at start of treatment, sex and category of PTB patient
(whether a new/ first time case of TB or a re treatment case).
ETHICS
Approval was obtained from the Ethekwini Municipality to access the medical records
at the Prince Cyril Zulu Communicable Diseases Centre for the specified time period.
The ethical approval was obtained from the Biomedical Research Ethics Committee of
the University Of KwaZulu- Natal South Africa, (Reference EXPO 44/06).
3.11 SUMMARY
A retrospective review was conducted to assess the efficacy of different methods of
Direct Observation of TB therapy offered to PTB patients between July 2005 and June
2006 at the Prince Cyril Zulu Communicable Diseases Centre in Durban, KwaZulu-Natal.
The study population consisted.ofadult patients who commenced a course ofTB therapy
for either a first episode of PTB or recurrence of PTB.
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Bivariate associations between outcomes and exposures were assessed using Pearson chi
square tests in the case of categorical exposures and independent t-tests for quantitative
variables. To account for possible confounding effects in assessing the independent
association between types of Direct Observation of TB therapy support on TB treatment
outcomes, binary logistic regression analysis was performed.
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4 CHAPTER IV: RESULTS
4.1 INTRODUCTION
The chart review of patients commencing therapy for pulmonary tuberculosis between
July 2005 and June 2006 at the Prince Cyril Communicable Diseases Centre yielded a
sample of 1211 participants who were included in the analysis. Sample size was limited
for the groups of family member DO, lay community volunteer DO and community
health worker DO to 203, 147 and 61 participants respectively.
Patients who had multi drug resistant PTB, extra pulmonary TB, who were initiated on a
trial of TB therapy by the attending clinician (not confirmed PTB), who were younger
than 17 years of age and those who were transferred out to other clinics and hospitals
were excluded from the sample population.
4.2 DEMOGRAPHIC CHARACTERISTICS OF THE STUD Y POPULA TION
The majority of patients were Black [1074 (88.7%)] and male [746, (62.4%)], The
median age of the study population was 34.6 years when therapy was commenced
(minimum age - 17.7 years; maximum age - 87.7 years)and the 25th to 75th inter quartile
range was 28.3 to 44.4 years. Nearly half (46%) of the sample reported being employed
although the employment status of26% (320) of the patients on treatment for PTB was
unknown.
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Table 2: Demographic characteristics of the 1211 patients with pulmonary
tuberculosis commenced on TB treatment at the Prince Cyril Zulu Communicable
Diseases Centre from July 2005 to June 2006


































































An equal number ofTS patients [400 (33%)] received Direct Observation ofTS therapy
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Figure I: Method of Direct Observation of therapy (percentage - number) of I2I]
pulmonary tuberculosis patients commenced on TB treatment from July 2005 to
June 2006 at the Prince Cyril Zulu Communicable Diseases Centre.
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4.3 TREATMENT OUTCOMES
A full course of TB treatment was successfully completed by 64.7% (784) of patients.
The remainder [427 (35.3%)] had interrupted treatment, failed treatment, died or were
lost to follow up.
Table 3: Treatment outcomes of 1211 pulmonary TB patients commenced on TB
























4.3.1 RISK FACTORS FOR UNSUCCESSFUL TUBERCULOSIS
TREATMENT OUTCOME:
Pearson Chi Square Test was used to check the validity of the assumptions. The
association between various risk factors and the tuberculosis treatment outcomes were
recalculated using logistic regression, adjusting for the following exposures of interest:
category (new or retreatment TB patient), method of direct observation, race, sex, age and
employment status. Method of direct observation, category of patient, employment status
and gender were the only remaining risk factors following adjustment for all risk factors
with backward stepwise modelling.
PTB patients who had workplace based Direct Observation had the best (73%) treatment
outcomes that were statistically significantly (p < 0.001) better than family member
supported Direct Observation (51.%) which was least successful (Table 4).
Although the adjusted odds ratio (OR=2.3; 95% Cl: 1.58 to 3.4; P <0.001) for
unsuccessful outcome of family member direct observation was lower than the crude
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odds ratio (OR=2.5; 95% Cl: !.to 3.62; p <0.001), family member Direct Observation
was still significantly more likely to result in an unsuccessful outcome than workplace
Direct observation. Clinic based Direct Observation (OR=l.4; 95% Cl: 0.99 to 1.91;
p=0.057), community health worker (OR=1.2; 95% Cl: 0.64 to 2.13; p=0.61) lay
community volunteer (OR=1.1; 95% Cl: 0.69 to 1.69; p=O.72) were more likely to have
unsuccessful treatment outcomes when compared to workplace based Direct Observation.
These findings were not statistically significant (Table 4).
New patients (patients who had never had TB previously) experienced a significantly
(p<O.OO 1) more successful treatment outcome (70 %) than patients who were being re-
treated (55 %), (Table 4). After adjustment of all other risk factors, patients who were
being treated for a subsequent episode of PTB (retreatment) were at a two times higher
risk of unsuccessful treatment outcome than new PTB patients (Adjusted OR=1.98; 95%
Cl: 1.53 to 2.56; p< 0.001) (Table 4).
Employed patients (72 %) also had better treatment outcomes compared to unemployed
patients (28% treatment success), (p < 0.001). Following adjustment for other risk factors
unemployed people (Adjusted OR = 1.64; 95 % Cl: 1.18 to 2.28; p= 0.003) and those
patients of unknown employment status (Adjusted OR = 1.60; 95 % Cl: 1.17 to 2.19; p=
0.003) had a 1.6 times higher risk of unsuccessful treatment outcome than employed
people (Table 4).
The most successful treatment outcomes were seen amongst Black patients (67%
treatment success), followed by Indian (61 %) and Coloured patients (51 %), (p<O.OI).
However, following adjustment for other risk factors race was not a significant risk factor
for unsuccessful treatment outcome (Table 4)..
Women were more likely to complete treatment successfully (68%) compared to men
(63%) (Adjusted OR = 1.44; 95% Cl: 1.11 to 1.87, p= 0.005) (Table 4).
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With every one year increase in age, beyond 17 years, the risk of treatment failure
increased by 1.01 times (95% Cl: 1.00 to 1.02; p=0.046), before adjustment for other risk
factors.
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Table 4: Risk factors for unsuccessful treatment outcome for 1211 pulmonary TB
patients commenced on TB treatment from July 2005 to June 2006 at the Prince
Cyril Zulu Communicable Diseases Centre.
Exposure Unsuccessful Treatment Total Crude P Adjusted P
variable Treatment success (n) Odds Ratio value Odds Ratio value
outcome (n=784) (%) (95% (95%
(n=427) No. (%) Confidence Confidence
No. (%) Intervals) Intervals)
Workplace 109(22.3%) 291(72.7%) 400 1 <0.001
DO (33%)
(reference)
Family 99 (48.8%) 104(51.2%) 203 2.54 <0.001 2.33 <0.001
member DO (16.8%) (1.79-3.62) (1.58-3.44)
Clinic DO 148(37.0%) 252(63.0%) 400 1.57 0.003 1.36 0.057
(33%) (1.16-2.11) (0.99-1.90)
Community 51 (34.7%) 96 (65.3%) 147 1.42 0.091 1.08 0.723
Volunteer (12.1 %) (0.95-2.13) (0.69-1.69)
DO
Community 20 (32.8%) 41 (67.2%) 61 1.30 0.371 1.17 0.606
Health (5.0%) (0.73-2.32) (0.64-2.13)
worker DO
Total 427(35.3%) 784 1211
(64.7%) (100%)
New 252(30.5%) 574 826 1 <0.001
treatment (69.5%) (68%)
(reference)
Re- 175(45.5%) 210 385 1.90 <0.001 1.98 <0.001
treatment (54.5%) (32%) (1.48-2.44) (1.53-2.56)
Total 427(35.3%) 784 1211
(64.7%) (100%)
Employed 156(28.3%) 395(71.7%) 551 <0.001
(reference) (46%)
Unemployed 145(42.6%) 195 340 1.88 <0.001 1.64 0.003
(57.4%) (28%) (1.42-2.50) (1.18-2.28)
Unknown 126(39.4%) 194 320 1.65 <0.001 1.60 0.003
(60.6%) (26%) (1.23-2.20) (1.17-2.19)
Total 427(35.3%) 784 1211
(64.7%) (100%)
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Table 4 (continued): Risk factors for unsuccessful treatment outcome for 1211
pulmonary TB patients commenced on TB treatment from July 2005 to June 2006
at the Prince Cyril Zulu Communicable Diseases Centre.
Exposure Unsuccessful Treatment Total Crude P Adjusted P
variable Treatment success (n) Odds Ratio value Odds Ratio value
outcome (n=812) (%) (95% (95%
(n=399) No. (%) Confidence Confidence
No. (%) Intervals) Intervals)
Black 365(34.0%) 709(66.0%) 1074 1
(reference) (89%)
Indian 31 (39.2%) 48 (60.8%) 79 1.26 0.343
(6.5%) (0.79-2.00)
Coloured 21 (48.8%) 22 (51.2%) 43 1.85 0.048
(3.5%) (1.01-3.42)
White 10 (66.7%) 5 (33.3%) 15 3.89 0.014
(1%) (1.32-
11.45)
Total 427(35.3%) 784 1211
(64.7%) (100%)
Female 146(32.1%) 309 455 1
(reference) (67.9%) (38%)
Male 281(37.2%) 475 756 1.3 0.073 1.44 0.005







4.4 RECURRENCE OF TB
Of the 772 patients who successfully completed treatment and for whom data on
recurrence was available, 10% (75 patients) experienced recurrence of TB within a two-
year follow up period (from June 2006 to August 2008).
4.4.1 RISK FACTORS FOR RECURRENCE OF TB:
Analysis for recurrence included 772 participants who had successfully completed
treatment since 12 participants were not included because of missing information on
recurrence. Category of patient (retreatment versus new PTB patients) was the only
remaining risk factor following adjustment for all risk factors with backward stepwise
modelling. Retreatment patients were at 2.1 times higher risk for recurrence when
compared to new patients (95% Cl: 1.29 to 3.432; p=0.003) (Table 5).
Family member Direct Observation demonstrated the highest frequency of recurrence
(13 %), (OR=I.12, 95% Cl: 0.57 to 2.24; p=0.739) and community health worker Direct
Observation the lowest frequency of recurrence (2.5%) but the results were not
statistically significant (OR =0.20; 95% Cl: 0.03 to 1.50; p= 0.285). Employed patients
showed a higher frequency of recurrence (10.1 %) when compared to unemployed
patients (8.8%), (OR = 0.86; 95% Cl; 0.47 to 1.55; p= 0.872) but again results were not
statistically significant. Coloured patients were more likely to have recurrent TB disease
(13.6%), (OR=I.44; 95% Cl: 0.42 to 4.99; p= 0.566) and White patients were least likely
(0.0%) to develop a subsequent episode of TB (OR = 0.00; 95% Cl: 0.00; p= 0.999).
Males were more likely to have recurrence (10.7%) than females (8.2%) (OR= 1.35; 95%
Cl: 0.82 to 2.24; p= 0.241).
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Table 5: Risk factors for recurrence of TB for 1211 pulmonary TB patients
commenced on a course of TB treatment from July 2005 to June 2006 at the Prince
Cyril Zulu Communicable Diseases Centre.
Exposure Recurrence Recurrence Total Crude P Adjusted P
variable No Yes (n) Odds Ratio value Odds value
(n=697) (n=75) (%) (95% Ratio)
No. (%) No. (%) Confidence (95%
Intervals) Confidence
Intervals)
Workplace 249(88.6%) 32 (11.4%) 281(36%)
DO
(reference)
Family 90(87.4%) 13(12.6%) 103(13%) 1.12 0.739
member DO (0.57-2.24)
Clinic DO 231(91.7%) 21(8.3%) 252(33%) 0.71 0.241
(0.39-1.26)
Community 88(91.7%) 8(8.3%) 96(12%) 0.71 0.403
Volunteer (0.31-1.59)
DO
Community 39(97.5%) 1(2.5%) 40(5%) 0.20 0.118
Health (0.03-1.50)
worker DO
Total 697(90%) 75(10%) 772(100%)
New 522(92.2%) 44(7.8%) 566(73%) 1
treatment
(reference)
Re- 175(85.0%) 31(15.0%) 206(27%) 2.10 0.003 2.10 0.003
treatment (1.29-3.43) (1.29-3.43)
Total 697(90%) 75(10%) 772(100%)
Employed 347(89.9%) 39(10.1%) 386 1
(reference) (50%)
Unemployed 177(91.2%) 17(8.8%) 194 0.86 0.606
(25%) (0.47-1.55)
Unknown 173(90.1%) 19(9.9%) 192 0.98 0.938
(25%) (0.55-1.74)
Total 697(90%) 75(10%) 772(100%)
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Table 5 (continued): Risk factors for recurrence of TB for 1211 pulmonary TB
patients from July 2005 to June 2006 at the Prince Cyril Zulu Communicable
Diseases Centre.
Exposure Recurrence Recurrence Total Crude P Adjusted P
variable No Yes (n) Odds value Odds Ratio value
(n=697) (n=75) (%) Ratio (95%





Black 629(90.1%) 69(9.9%) 698 1
(reference) (90%)
Indian 44(93.6%) 3(6.4%) 47 0.62 0.436
(6%) (0.19-
2.06)
Coloured 19(86.4%) 3(13.6%) 22 1.44 0.566
(3%) (0.42-
4.99)
White 5(100.0%) 0(0.0%) 5 0.00 0.999
(1%) (0.00)
Total 697(90%) 75(10%) 772(100
%)
Female 281(91.8%) 25(8.2%) 306 1
(reference) (40%)
Male 416(89.3%) 50(10.7%) 466 1.35 0.241
(60%) (0.82-
2.24)
Total 697(90%) 75(10%) 772(100
%)
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4.5 SUB ANALYSIS OF EMPLOYED PATIENTS
Of the total sample size of 1211 patients, 551 (46 %) were employed and were included
in the analysis. Three hundred and forty patients (28%) reported to be unemployed and
the employment status for 320 patients (26%) was unknown. Seventy two percent of
employed patients completed treatment successfully. The employment status for patients
allocated to the different methods of Direct Observation is indicated in Table 6. The
majority of employed patients opted for workplace supervision (55%) and about a quarter
of employed patients were supervised at a clinic (26%). Of the patients that received
workplace supervision 75% were employed, 5% had reported that they were unemployed
and the employment status of 20% was not known.
Table 6: Employment status for 1211 pulmonary TB patients commenced on TB
therapy from July 2005 to June 2006 at the Prince Cyril Zulu Communicable
Diseases Centre.
Employment Workplace Family Clinic DO Community Community Total
status DO member (n=400) volunteer health
(n=400)) DO No. (%) DO worker
No. (%) (n=203) (n=147) DO
No. (%) No. (%) (n=61)
No. (%)
Employed 302(54.8%) 52(9.4%) 141(25.6%) 25(4.5%) 31(5.6%) 551(46%)
Unemployed 20(5.9%) 88(25.9%) 143(42.1%) 74(21.8%) 15(4.4%) 340(28%)
unknown 78(24.4%) 63(19.7%) 116(36.3%) 48(15%) 15(4.7%) 320(26%)
Total 400 (33%) 203(16.8%) 400(33%) 147(12.1%) 61(5%) 1211(100%)
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4.5.1 RISK FACTORS FOR UNSUCCESSFUL TB TREATMENT OUTCOME
AMONGST EMPLOYED PATIENTS:
Lay community health volunteer Direct Observation of treatment had better treatment
outcomes (84.0%) than workplace Direct Observation (72.8%). Workplace Direct
Observation was only marginally better than clinic Direct Observation (70.9%) and
family member Direct Observation had the least successful outcome (61.5%). However,
the results were not statistically significant (p=0.313) (Table 7).
Indian employed patients had the best treatment outcomes (84%), followed by Black
patients (71.3%), Coloured patients (70.0%) and White patients (33.3%). These results
were not statistically significant (p=0.252).
Female employed patients were least likely not to complete treatment successfully
(21.6%) when compared to their male counterparts (treatment failure 31.1 %). These
results were statistically significant (p=0.024).
New TB patients showed a statistically better treatment outcome (76.1 %) when compared
to retreatment patients (62.4%), (p<O.OOl).
After adjusting for the effect of race, sex, age at treatment start, category of patient and
method of Direct Observation, the effect of method of Direct Observation was not found
to be statistically significant (p=O.ll). Family member Direct Observation was
significantly more likely not to succeed when compared to workplace Direct Observation
(p=0.025). Male employed patients were 1.7 times more likely not to complete
treatment than female patients were (p=O.O18). Retreatment was still a significant risk for
unsuccessful treatment outcome when compared to new cases (p <0.001).
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Table 7: Risk factors for unsuccessful treatment outcome for 551 employed
pulmonary TB patients commenced on TB treatment from July 2005 to June 2006
at the Prince Cyril Zulu Communicable Diseases Centre.
Exposure Unsuccessful Treatment Total Crude Odds P Adjusted P
variable Treatment success (n) Ratio (95% value Odds Ratio value
outcome (n=8I2) (%) Confidence (95%
(n=399) No. (%) Intervals) Confidence
No. (%) Intervals)
Workplace 82 (27.2%) 220 302 1 0.110
DO (72.8%) (55%)
(reference)
Family 20 (38.5%) 32 (61.5%) 52 1.69 0.340 2.07 0.025
member (9%) (0.90-3.17) (1.09-3.91)
DO
Clinic DO 41 (29.1%) 100 141 1.27 0.102 1.36 0.585
(70.9%) (25%) (0.81-1.99) (0.72-1.78)
Community 4 (16.0%) 21 (84.0%) 25 0.61 0.377 1.08 0.171
Volunteer (5%) (0.20-1.83) (0.15-1.40)
DO
Community 9 (29.0%) 22 (71.0%) 31 1.31 0.522 1.17 0.694
Health (6%) (0.73-2.32) (0.51-2.73)
worker DO
Total 156(28%) 395 (72%) 551
(100%)
New 89(23.9%) 284(76.1) 373 1
treatment (68%)
(reference)
Re- 67(37.6%) 111(62.4%) 178 1.71 0.008 1.71 0.018
treatment (32%) (1.15-2.53) (1.09-2.68)
Total 156(28%) 395(72%) 551
(100%)
Black 147(28.7%) 366(71.3%) 513 1
(reference) (93.5%)
Indian 4(16%) 21(84%) 25 0.54 0.265
(4%) (0.18-1.60)
Coloured 3(30.0%) 7(70.0%) 10 1.21 0.783
(2%) (0.31-4.76)




Table 7 (continued): Risk factors for unsuccessful treatment outcome for 551
employed pulmonary TB patients commenced on TB treatment from July 2005 to
June 2006 at the Prince Cyril Zulu Communicable Diseases Centre.
Exposure Unsuccessful Treatment Total Crude P Adjusted P
variable Treatment success (n) Odds Ratio value Odds Ratio value
outcome (n=812) (%) (95% (95%
(n=399) No. (%) Confidence Confidence
No. (%) Intervals) Intervals)
Female 35(21.6%) 127(78.4%) 162 1
(reference) (29%)
Male 121(31.1%) 268(68.9%) 389 1.62 0.033 1.97 0.001
(71%) (1.04-2.54)
Total 156(28%) 395(72%) 551
(100%)
RISK FACTORS FOR TB RECURRENCE AMONGST EMPLOYED
PATIENTS:
Analysis for recurrence of TB included 386 employed patients who had successfully
completed treatment. Nine participants were excluded because of missing information on
recurrence. Recurrence of TB occurred in 10.1% of employed patients.
Workplace Direct Observation showed the highest risk of recurrence followed by family
member, community volunteer, clinic based and community health worker Direct
Observation in decreasing order of recurrence of TB but the results were not statistically
significant (p= 0.253) (Table 8).
Recurrence of TB was highest amongst Coloured patients, followed by Black, Indian and
White patients but again results were not statistically significant (p=0.839). Male patients
were more likely to have recurrent TB (10.4%) in comparison to females (9.5%),
(p=0.792). Retreatment employed TB patients were significantly more likely to have a
recurrent episode of TB (16.5%) than new patients were (7.6%), (p= 0.009).
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Retreatment was the only significant exposure variable for recurrence following binary
logistic regression analysis with the use of backwards stepwise models utilized to assess
the independent association between exposure variables and recurrence of TB (table 8).
Retreatment patients were 2.4 times more likely to experience a recurrent episode of TB
than new TB patients (95% Cl: 1.23 - 4.74; p =0.01).
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Table 8: Risk factors for recurrence of TB amongst 386 employed TB patients
commenced on TB treatment from July 2005 to June 2006 at the Prince Cyril Zulu
Communicable Diseases Centre.
Exposure Recurrence Recurrence Total Crude P Adjusted P




Workplace 185(87.3%) 27(12.7%) 212(56%) 1
DO
(reference)
Family 28(87.5%) 4(12.5%) 32(8%) 0.98 0.970
member (0.32-3.01)
DO
Clinic 95(87.5%) 5(12.5%) 100(26%) 0.36 0.043
DO (0.14-0.97)
Community 19(90.5%) 2(9.5%) 21(5%) 0.72 0.672
Volunteer (0.16-3.27)
DO
Community 20(95.2%) 1(4.8%) 21(5%) 0.34 0.343
Health (0.04-2.660
worker DO
Total 347(90%) 39(10%) 386(100%)
New 256(92.4%) 21(7.6%) 277(72%) 1
(reference)
Retreatment 91(83.5%) 18(16.5%) 109(28%) 2.40 0.010 2.41 0.010
(1.23-4.73) (1.23-4.73)
Total 347(90%) 39(10%) 386(100%)
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Table 8 (continued): Risk factors for recurrence of TB amongst 386 employed TB
patients commenced on TB treatment from July 2005 to June 2006 at the Prince
Cyril Zulu Communicable Diseases Centre.
Exposure Recurrence Recurrence Total Crude P Adjusted P




Black 321(89.7%) 37(10.3%) 358 1
(reference) (93%)
Indian 19(95.0%) 1(5.0%) 20 0.46 0.451
(5%) (0.06-3.51 )
Coloured 6(85.7%) 1(14.3%) 7 1.45 0.736
(2%) (0.17-
12.34)
White 1(100%) 0(0%) 0.00 1.000
(0.00)
Total 347(90%) 39(10%) 386(100%)
Female 114(90.5%) 12(9.5%) 126 1
(reference)
Male 233(89.6%) 27(10.4%) 260 1.10 0.793
Total 347(90%) 39(10%) 386(100%)
SUMMARY
The majority of patients in this study were from the black community, male, with a
median age of 35 years at start of treatment. Less than half of the patients were
employed.
In this analysis, equal numbers of patients received workplace and clinic based Direct
Observation of TB therapy. Family member based Direct Observation, community health
worker Direct Observation and lay community volunteer groups did not meet the sample
size requirement of 400 patients.
Sixty five percent of patients had a successful treatment outcome and, of these for whom
data was, available, ten percent experienced a recurrence of TB.
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Multivariate analysis to assess the independent risk of each one of the exposure variables/
risk factors demonstrated that retreatment patients were more likely to have unsuccessful
treatment outcomes and recurrence. Workplace supervision of TB treatment, female
gender, black, employed patients were more likely to have successful treatment
outcomes.
To control for the possible confounding effect of employment status a subgroup analysis
of employed patients was done. The overall effect of method of Direct Observation was
not statistically significant but family member Direct Observation was the only method of
Direct Observation which was significantly more likely to have an unsuccessful TB
treatment outcome when compared to workplace Direct Observation. Male patients and
retreatment cases of TB were more likely to fail treatment. Amongst employed patients,




The study evaluated the effectiveness of five different methods of Direct Observation of
TB therapy (clinic based supervision, family member supervision, workplace based
supervision, community health worker supervision and lay community volunteer
supervision) on PTB treatment outcomes and recurrence of TB following successful
treatment completion in a resource constrained setting with a high burden of
Tuberculosis. The findings of this study are generalizable to other developing countries
where challenges in implementation of an effective TB programme such as poverty, high
burden of co morbid illnesses such as HIV infection, a migrant population with strong
rural ties and reliance on traditional practices to cure illness, play a major role.
5.2FINDINGS
The successful treatment completion rate of 65% was below the WHO target and that of
71 % achieved for South Africa as a whole in 2005. 5 It was similar to the 64%
successful treatment completion rate achieved for KwaZulu-Natal achieved in 2005 5 and
thus maybe assumed that similar challenges in improving cure rates are faced by most TB
facilities in the province. The sub optimal cure rates achieved in this facility could also
be attributed to the migratory nature of the patient population, a factor which may have
affected the level of adherence to TB treatment.
Recurrence:
Of those that had a successful outcome and for whom data on recurrence was available,
10% experienced recurrence of TB. This is similar to the recurrence range of 0% to 14%
reported in other studies. 7 Severity of disease, bacteriological response time to TB
treatment and the total amount of chemotherapy taken has been identified as predictors of
recurrent TB. It is reasonable to assume that patients who continue with employment and
receive work place Direct Observation whilst on TB treatment have less severe disease.
In addition these patients do not have the inconvenience of travelling to their treatment
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supporters and should therefore be adherent to treatment and thus have lower recurrent
TB when compared to the other groups. Therefore discerning the reason for the higher
incidence of recurrence amongst patients receiving work placed Direct Observation, who
had the most successful treatment outcome initially, is challenging.
Direct Observation of TB Therapy:
Analysis of treatment outcome by Direct Observation supervision method demonstrated
that workplace based supervision had a higher frequency of successful treatment outcome
than the other methods of Direct Observation (p < 0.001), with family member support
being the least successful. The assumption that patients receiving workplace supervision
of treatment had less severe disease and did not have the inconvenience and expense
associated with travelling to the Direct Observation supporter would account for the more
successful outcome in this group of patients.
A study based in South Africa that evaluated workplace supervision also found this
method of Direct Observation to be superior to clinic based and community based Direct
Observation. In the study conducted by Sinanovic et al. 20 workplace management of TB
extended beyond just direct observation of TB therapy. It included the diagnosis of
tuberculosis and clinical and laboratory monitoring of response to TB therapy.
In this study, family member Direct Observation was 2.3 times more likely than
workplace support to result in unsuccessful treatment outcome. This is in contrast to a
study were it was found to be superior 11 or equivalent to other methods of Direct
Observation. 9 In a randomized cluster trial conducted in Senegal, Thiam et al. 12
demonstrated that family member supervision was superior to supervision by community
health workers and clinic nurses. Family member supervision achieved cures of 88%,
compared with 77% in the other two groups. The treatment interruption was also much
lower in the patients who were supervised by family members. The outcome of a cluster-
randomized trial conducted by Newell et al 9 in Nepal demonstrated that family member
supervision and community worker Direct Observation of TB treatment were equally as
effective in ensuring adherence to TB treatment. Family supervision exceeded the WHO
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target cure rate of 85% and community worker supervision met the WHO target.
However, it has been commented that the findings of Thiam et al. 11 in Senegal lacked
external validity, as it was not conducted under programmatic conditions (the study
would be difficult to duplicate under field conditions in under resourced areas because
supervisors received enhanced training and monitoring throughout the study). 7
Clinic based Direct Observation was more likely to be unsuccessful when compared to
workplace Direct Observation. The finding is in contrast to the findings of a chart review
done amongst TB patients that share similar characteristics to patients at the eThekwini
site. In the study conducted in India, clinic based Direct Observation increased successful
TB treatment outcomes from 55% to 95%. 10
Long waiting times and inconvenient hours of operation, often make clinic based Direct
Observation unacceptable to patients, especially if it limits their ability to fulfil their work
obligations.
Patients allocated to lay community volunteer and community health worker Direct
Observation were less likely to experience unsuccessful treatment outcome when
compared to clinic based, and family member Direct Observation of TB therapy.
However, these results were not statistically significant which is probably related to the
small sample sizes in these groups.
Patient gender:
Females were more likely to successfully complete treatment and this is in accordance
with findings of other studies. 15,19 A randomized controlled trial conducted by Walley et
al. 15 evaluating the efficacy of self supervision, health worker supervision and family
member Direct Observation on TB treatment outcomes in Pakistan demonstrated that
male patients were more likely to be non adherent to TB treatment when compared to
female patients (38% versus 23%). A prospective cohort study evaluating the
effectiveness of community volunteer Direct Observation on TB treatment outcomes in
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South Africa demonstrated that males were significantly more likely to fail TB treatment
(OR =1.38; 95% Cl: 1.02 to 1.87). 19
Employment status:
A higher proportion of employed patients (72%) had successful TB treatment outcomes
when compared to the study population as a whole (65%). Unemployed people were at
greater risk of treatment failure than employed people were. Unemployed patients would
tend to have a lower socioeconomic status and other comorbid illnesses, which would
impact on adherence and response to TB treatment.
An analysis of employed patients showed that method of Direct Observation had no
overall effect on TB treatment outcomes although family member Direct Observation was
significantly more risky for unsuccessful treatment outcome than workplace Direct
Observation. Amongst employed patients, retreatment patients were more likely to have
TB recurrence when compared to new cases of PTB.
An observed anomaly is that, of the patients that received workplace supervision 5% had
reported that they were unemployed and the employment status of 20% was unknown. It
has been noted by clinicians that TB patients often do not disclose their employment
status correctly in order to enhance their chances to qualifY for a disability grant for
which employed individuals are ineligible (anecdotal evidence). This could be a possible
reason for the noted anomaly of employment status amongst patients receiving workplace
Direct Observation.
A little over half of the employed patients opted for workplace Direct Observation whilst
a quarter chose clinic based Direct Observation. Employed patients often do not disclose
that they are on TB treatment to their employers and co-workers for fear of dismissal
from employment This could account for nearly 45% of employed individuals choosing
other methods of Direct Observation over workplace Direct Observation. Severe TB
disease and an inability to return to employment at the time of commencement of TB
treatment could also account for employed patients opting for other methods of Direct
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Observation. In addition, employed patients receiving streptomycin as part of a re
treatment TB regimen would have been allocated to clinic based supervision if an
occupational health facility was not accessible.
Category ofTE patients:
Retreatment, patients exhibited a significantly higher risk of unsuccessful treatment
outcome than new TB patients did confirming the finding in the study conducted by
Zwarenstein et al. 14 Retreatment was also the only significant risk factor associated with
recurrence of TB following prior successful treatment completion. If a high incidence of
MDR TB existed amongst re treatment patients, it would explain the higher risk of
unsuccessful treatment outcomes in this group of patients. A diagnosis of MDR TB is
often only arrived at once sputum culture results become available about 6 weeks after a
patient has been commenced on standard first line TB treatment. The incidence of MDR
TB was not measured in this study.
5.3 VALIDITY
Internal validity:
A retrospective cohort study does not constitute the ideal study design to answer the
research question. A randomized controlled study remains the gold standard in study
design and would have improved the internal validity of the study. The current study was
conducted under programmatic conditions and, thus, not all effect modifiers, confounders
and bias could be controlled for or eliminated. However, to improve the internal validity
of this study, binary logistic regression was conducted to control for the effect of
confounders and to assess the independent effect of method of Direct Observation of TB
therapy on TB treatment outcomes. Odds ratios were used as the measure of association
(although unsuccessful treatment outcome is not a rare outcome so the association may
be an overestimate) because the outcome and exposures were assessed simultaneously
(that is, there was no time to event).
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The odds ratio for unsuccessful treatment outcome was reported on instead of the odds
ratio for treatment success because in logistic regression the odds ratio for the "disease"
outcome (unsuccessful treatment outcome - in this study) in case control studies is
traditionally calculated. The outcome indicator used by the WHO however is treatment
success.
External validity:
The study was performed under programmatic conditions. As the data was collected
retrospectively, providers and patients could not have exhibited a social desirability bias.
They did not receive any additional intervention other than that prescribed by the South
African National TB Programme and, thus, the results of this study are generalizable to
managing Direct Observation of TB in other developing countries.
5.4 BIAS AND LIMITATIONS
The study was undertaken under routine programmatic conditions and maybe affected by
some bias and limitations.
Clinic based Direct Observation was not aggregated into daily or weekly clinic based
Direct Observation in the analysis. From personal experience at the clinic, it was
observed that some patients were supported daily and others supported weekly. This is a
limitation of the study.
Some patients who received workplace based Direct Observation were supervised by
occupational health nurses, located in the workplace, and although supervision by
occupational health nurses is considered as part of workplace Direct Observation this
could have influenced adherence and TB treatment outcomes, as nurses have better
counselling skills and knowledge on TB management when compared to other work
place based supervisors.
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The limitation associated with measurement of recurrence in this study is that passive
follow up was employed to determine whether recurrence had occurred or not (patient
charts were reviewed to determine whether patients had returned to the site for
management ofa subsequent episode of TB.) An assumption was made that patients
would return to the same site in the event of developing symptoms of a subsequent
episode of TB; therefore, under reporting of recurrence is likely to have occurred.
In addition, it is not possible to differentiate between relapse of the same infection or re-
infection by a new strain of Mycobacterium tuberculosis.
Misc1assification bias
Studies have found that patients do not comply consistently with the original method of
Direct Observation allo(:ation. A randomized controlled trial conducted by Walley et al.
15 in Pakistan demonstrated that 16 percent of patients allocated to health worker Direct
Observation and 2% of patients allocated to family member Direct Observation did not
comply with original method of Direct Observation of TB therapy. 15
A chart review conducted in Kerela, India by Balasubramanian et al. 10 found that
implementation of Direct Observation of TB therapy was a challenge following allocation
to a Direct Observation method (about 25% of patients and health workers did not
comply with Direct Observation).
In this study, there is no means to verify that the method of Direct Observation agreed
upon, was actually practiced through out the period of TB therapy. Therefore,
misc1assification bias may have arisen.
Documentation of employment status is dependent on patient self-report and could have




The severity of the preceding episode of TB disease has been independently associated
with recurrence of TB (presence of cavitations and more extensive lung involvement) and
this study is limited in not taking this factor into account. 6
The presence of comorbid illnesses such as HIV infection could also affect TB treatment
outcomes. Unfortunately, the prevalence of HIV infection could not be assessed in this
study as patient acceptance of voluntary counseling and testing for HIV infection and the
extent of disclosure of HIV status was low when this study was implemented.
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CHAPTER VI: RECOMMENDATIONS AND CONCLUSIONS
6.1 INTRODUCTION
The high burden of tuberculosis results in clinic based observation not always proving
feasible, both for the patient and the provider. Therefore, other effective methods of
Direct Observation of TB therapy need to be considered. Studies implemented have not
proven the superiority of anyone method of Direct Observation.
6.2 CONCLUSIONS
For employed TB patients Direct Observation at the workplace has proved to be the most
effective option in this study. This method of Direct Observation needs to be considered
by other facilities to ensure that employed patients are not absent from work when they
are required to report to treatment supervisors for direct observation of TB treatment.
This will help to ensure that patients remain employed and in a position to fulfil the
financial obligations, they have to their families and continue to be productive members
of society.
6.3 RECOMMENDATIONS
Sample size limitations for family member, community health worker and lay volunteer
direct observation methods do not allow for the unequivocal recommendation of
workplace based supervision of TB therapy as the preferred method of observation for
employed TB patients. Nevertheless, the findings of this study strongly suggest that this
method of Direct Observation can have a significant impact in improving TB treatment
outcomes.
There is often no best treatment observer. Every case has to be individually evaluated
(taking into account patient, provider and disease factors) and the most acceptable and
accessible treatment observer chosen. If family member Direct Observation forms the
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only option for supervision, then family members should receive enhanced education on
TB and should receive intensive supervision and home visits by a clinic based health care
worker.
TB treatment is delivered to the workplace by clinic staff; at a TB clinic in the suburbs of
Durban (Pinetown), for those individuals who choose workplace based Direct
Observation. This contact with workplace based supervisors of TB treatment by TB
clinic staff promotes a cordial relationship between the clinic and workplace staff and
ensures that TB clinic staff is aware of those patients that are not adherent to TB
treatment timeously. Delivery of TB treatment to the workplace, if practised by the staff
of the Prince Cyril Zulu Communicable Diseases Centre, could increase adherence to TB
treatment and ultimately result in more successful TB outcomes amongst employed TB
patients.
6.4 RECOMMENDATION FOR FURTHER STUDY
Future studies evaluating recurrence, need to take cognisance of the severity of TB
disease by taking into consideration chest radiography findings and scoring severity of
disease according to radiological findings.
In addition, planned studies should take into consideration patients' HIV infection status
and level of disability.
Patients and providers interviews should be implemented to determine whether there is
adherence to method of Direct Observation initially agreed to. Reasons for non-
adherence to method of Direct Observation may be explored during interviews. This
information will be vital in improving adherence to TB treatment.
Retreatment patients demonstrated poor treatment outcomes and higher frequency of
recurrence of a subsequent episode of TB; therefore, future studies are required to
evaluate effective interventions to improve treatment outcomes in this group of patients.
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It has been noted that Direct Observation in this group of patients is ineffective and
qualitative studies involving in- depth interviews is required in this group of patients to
determine the reasons for the failure of Direct Observation. 14
Ideally, a randomized trial should be considered which would increase the internal
validity of this study. A randomized study evaluating the effect of different methods of
Direct Observation amongst employed patients (a group in which 72% of patients had
successful TB treatment outcome) may yield vital information on the ideal method of
Direct Observation of TB treatment.
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APPENDIX 1 - DATA COLLECTION TOOL
THE PRINCE Patient Date Age at Date Patient Race Employment Method of Five Date TB Recurrence
CYRIL ZULU number Treat treatment treatment Category status DO month of Treatment Yes/no
COMMUNICABLE
Starts start ends (new/re supervision sputum last Outcome
DISEASES
CENTRE treatment result visit
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Dear Or Nair
A sub'committee of the Biomedical Research Ethics Committee has considered and noted
your response received 23 March 2007 to queries raised on 24 NOYerOOer 2006.
We also confirm receipt of the outstanding pefrmssion tetter from the hospital manager of
Prince Cyril Zulu Communicable Diseases Centre.
The study is given flAl ethics approval and may begin as at today's date: 26 March 2007.
This approval is valid for one year from 26 March 2007. To ensure continuous approval,
an application for recertification should be sWmitted a couple of months before the expiry
date. In addition, when consent is a requirement, the consent process will need to be
repeated annually.
I take this opportunity to wish you everything of the best with your study. Please send the
Biomedical Research Ethics Convnittee iI c:opv of your report once completed.
The sub-eommittee's decision will be RATIFIED at a fun sitting of the Biomedical Research
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